These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 24120836)

  • 1. Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies.
    Swomley AM; Förster S; Keeney JT; Triplett J; Zhang Z; Sultana R; Butterfield DA
    Biochim Biophys Acta; 2014 Aug; 1842(8):1248-57. PubMed ID: 24120836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox proteomics and amyloid β-peptide: insights into Alzheimer disease.
    Butterfield DA; Boyd-Kimball D
    J Neurochem; 2019 Nov; 151(4):459-487. PubMed ID: 30216447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress, protein modification and Alzheimer disease.
    Tramutola A; Lanzillotta C; Perluigi M; Butterfield DA
    Brain Res Bull; 2017 Jul; 133():88-96. PubMed ID: 27316747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress in Alzheimer disease and mild cognitive impairment: evidence from human data provided by redox proteomics.
    Swomley AM; Butterfield DA
    Arch Toxicol; 2015 Oct; 89(10):1669-80. PubMed ID: 26126631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.
    Sultana R; Perluigi M; Butterfield DA
    Acta Neuropathol; 2009 Jul; 118(1):131-50. PubMed ID: 19288120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment.
    Butterfield DA
    Free Radic Biol Med; 2014 Sep; 74():157-74. PubMed ID: 24996204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression.
    Butterfield DA; Swomley AM; Sultana R
    Antioxid Redox Signal; 2013 Sep; 19(8):823-35. PubMed ID: 23249141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.
    Butterfield DA
    Free Radic Res; 2002 Dec; 36(12):1307-13. PubMed ID: 12607822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do proteomics analyses provide insights into reduced oxidative stress in the brain of an Alzheimer disease transgenic mouse model with an M631L amyloid precursor protein substitution and thereby the importance of amyloid-beta-resident methionine 35 in Alzheimer disease pathogenesis?
    Sultana R; Robinson RA; Lange MB; Fiorini A; Galvan V; Fombonne J; Baker A; Gorostiza O; Zhang J; Cai J; Pierce WM; Bredesen DE; Butterfield DA
    Antioxid Redox Signal; 2012 Dec; 17(11):1507-14. PubMed ID: 22500616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.
    Butterfield DA; Reed T; Newman SF; Sultana R
    Free Radic Biol Med; 2007 Sep; 43(5):658-77. PubMed ID: 17664130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer's Disease.
    Butterfield DA; Boyd-Kimball D
    J Alzheimers Dis; 2018; 62(3):1345-1367. PubMed ID: 29562527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease.
    Perluigi M; Di Domenico F; Butterfield DA
    Physiol Rev; 2024 Jan; 104(1):103-197. PubMed ID: 37843394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression and redox proteomics analyses of an Alzheimer disease transgenic mouse model: effects of the amyloid-β peptide of amyloid precursor protein.
    Robinson RA; Lange MB; Sultana R; Galvan V; Fombonne J; Gorostiza O; Zhang J; Warrier G; Cai J; Pierce WM; Bredesen DE; Butterfield DA
    Neuroscience; 2011 Mar; 177():207-22. PubMed ID: 21223993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rodent Abeta(1-42) exhibits oxidative stress properties similar to those of human Abeta(1-42): Implications for proposed mechanisms of toxicity.
    Boyd-Kimball D; Sultana R; Mohmmad-Abdul H; Butterfield DA
    J Alzheimers Dis; 2004 Oct; 6(5):515-25. PubMed ID: 15505374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and the amyloid beta peptide in Alzheimer's disease.
    Cheignon C; Tomas M; Bonnefont-Rousselot D; Faller P; Hureau C; Collin F
    Redox Biol; 2018 Apr; 14():450-464. PubMed ID: 29080524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative modification of brain proteins in Alzheimer's disease: perspective on future studies based on results of redox proteomics studies.
    Sultana R; Butterfield DA
    J Alzheimers Dis; 2013; 33 Suppl 1():S243-51. PubMed ID: 22683528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death.
    Butterfield DA; Castegna A; Lauderback CM; Drake J
    Neurobiol Aging; 2002; 23(5):655-64. PubMed ID: 12392766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial dysfunction: different routes to Alzheimer's disease therapy.
    Picone P; Nuzzo D; Caruana L; Scafidi V; Di Carlo M
    Oxid Med Cell Longev; 2014; 2014():780179. PubMed ID: 25221640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease.
    Behl C
    Cell Tissue Res; 1997 Dec; 290(3):471-80. PubMed ID: 9369525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer's disease.
    Verri M; Pastoris O; Dossena M; Aquilani R; Guerriero F; Cuzzoni G; Venturini L; Ricevuti G; Bongiorno AI
    Int J Immunopathol Pharmacol; 2012; 25(2):345-53. PubMed ID: 22697066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.